Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEBIRI-TACE
2012-000987-11Phase 2Terminated
- Sponsor
- Anni Ravnbek Jensen
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of irinotecan in colorectal cancer (CRC), sponsored by Anni Ravnbek Jensen. Primary endpoint: Frequency of surgical resection and/or radiofrequency ablation. Started May 2012; status: terminated.
02
Drugs
irinotecan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2012-000987-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000987-11.